Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy

Bladder cancer is one of the concerning urological malignant diseases in the world, which has a clinical need for effective targeted therapy. The development of nanotechnology-based gene delivery to bladder tumor sites is an effective strategy for targeted cancer therapy with low/no toxicity. With t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahidi, Maryamsadat, Abazari, Omid, Dayati, Parisa, Bakhshi, Ali, Zavarreza, Javad, Modarresi, Mohammad Hossein, Haghiralsadat, Fateme, Rahmanian, Mehdi, Naghib, Seyed Morteza, Tofighi, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388766/
https://www.ncbi.nlm.nih.gov/pubmed/35992340
http://dx.doi.org/10.3389/fbioe.2022.949704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388766/
https://www.ncbi.nlm.nih.gov/pubmed/35992340
http://dx.doi.org/10.3389/fbioe.2022.949704

Ejemplares similares